Pharma-Bio Serv (PBSV) Net Margin (2016 - 2025)
Historic Net Margin for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to 0.0%.
- Pharma-Bio Serv's Net Margin fell 7000.0% to 0.0% in Q4 2025 from the same period last year, while for Oct 2025 it was 1.22%, marking a year-over-year increase of 69600.0%. This contributed to the annual value of 1.12% for FY2025, which is 70600.0% up from last year.
- Per Pharma-Bio Serv's latest filing, its Net Margin stood at 0.0% for Q4 2025, which was down 7000.0% from 10.89% recorded in Q3 2025.
- Over the past 5 years, Pharma-Bio Serv's Net Margin peaked at 45.61% during Q3 2021, and registered a low of 87.05% during Q4 2021.
- In the last 5 years, Pharma-Bio Serv's Net Margin had a median value of 3.84% in 2022 and averaged 1.0%.
- As far as peak fluctuations go, Pharma-Bio Serv's Net Margin crashed by -899300bps in 2021, and later soared by 907900bps in 2022.
- Pharma-Bio Serv's Net Margin (Quarter) stood at 87.05% in 2021, then surged by 104bps to 3.74% in 2022, then crashed by -135bps to 1.31% in 2023, then soared by 153bps to 0.69% in 2024, then plummeted by -101bps to 0.0% in 2025.
- Its last three reported values are 0.0% in Q4 2025, 10.89% for Q3 2025, and 3.95% during Q2 2025.